Global Hyperthermia Treatment for Cancer Market Report (2026–2036)
Market Overview
The global hyperthermia treatment for cancer market is projected to grow steadily during 2026–2036, driven by rising cancer prevalence, increasing adoption of adjunctive therapies, and technological advancements in hyperthermia devices. Hyperthermia therapy involves heating tumor tissues to enhance the effectiveness of radiation and chemotherapy, reduce tumor resistance, and improve patient outcomes.
Key Players
In addition to the listed manufacturers, the following companies are also significant participants in the global hyperthermia treatment for cancer market:
- Andromedic Sri (Italy)
- Celsius42 GmbH (Germany)
- Huahang (China)
- Pyrexar Medical (US)
- Perseon Medical (US)
- Omron Corporation (Japan)
- Sjn AG Yamamoto Vinita (Japan)
- BSD Medical (US)
- Oncotherm Kft. (Hungary)
- ThermoTek Inc. (US)
- MedicaTherm (Germany)
- Alba Hyperthermia Systems (Spain)
These players compete on innovation, device safety, clinical validation, regulatory approvals, and distribution networks.
Segments Analysis
By Product Type
- Microwave Hyperthermia Devices – Widely used for localized tumor heating.
- Ultrasound Hyperthermia Devices – Non-invasive, precise targeting of tumor tissues.
- Infrared Therapy Devices – Applied for superficial tumors.
- Short-wave Therapy Devices – Used for deep tissue heating.
By Application
- Hospitals – Largest segment; demand driven by oncology departments.
- Clinics – Growing adoption in outpatient cancer treatment centers.
- Research Institutes – Focused on clinical trials, innovation, and device validation.
Regional Analysis
- North America – Largest market; US leads due to advanced oncology infrastructure and high cancer prevalence.
- Europe – Significant adoption in Germany, UK, and France; focus on clinical validation and reimbursement policies.
- Asia-Pacific – Fastest-growing region; China, India, and Japan drive growth due to rising cancer cases and expanding healthcare facilities.
- South America – Brazil and Argentina show increasing adoption in urban hospitals.
- Middle East & Africa – Emerging demand in Saudi Arabia, Turkey, and South Africa, supported by expanding oncology care infrastructure.
Porter’s Five Forces
- Threat of New Entrants – Moderate; requires advanced R&D, clinical validation, and regulatory approvals.
- Bargaining Power of Suppliers – Moderate; specialized components and biomaterials influence pricing.
- Bargaining Power of Buyers – High; hospitals demand cost-effective, clinically validated devices.
- Threat of Substitutes – Moderate; alternatives include conventional radiation and chemotherapy.
- Industry Rivalry – High; strong competition among global and regional manufacturers.
SWOT Analysis
Strengths
- Proven efficacy in enhancing radiation and chemotherapy outcomes.
- Wide adoption across hospitals and research institutes.
- Established global players with advanced R&D.
Weaknesses
- High costs of advanced hyperthermia devices.
- Limited awareness among patients and providers.
- Dependence on regulatory approvals.
Opportunities
- Rising prevalence of cancer worldwide.
- Expansion into emerging markets with growing oncology infrastructure.
- Growth in minimally invasive hyperthermia technologies.
Threats
- Competition from alternative cancer therapies.
- Price sensitivity in cost-conscious healthcare systems.
- Stringent regulatory requirements across regions.
Trend Analysis
- Increasing adoption of non-invasive ultrasound hyperthermia devices.
- Rising popularity of combination therapies integrating hyperthermia with immunotherapy.
- Growth in AI-driven treatment planning and monitoring.
- Expansion of portable and outpatient hyperthermia systems.
- Development of eco-friendly and biocompatible device materials.
Drivers & Challenges
Drivers
- Rising global cancer prevalence.
- Expanding demand for adjunctive therapies to improve treatment outcomes.
- Technological advancements in hyperthermia device design.
Challenges
- High costs of devices and procedures.
- Regulatory hurdles in medical device approvals.
- Limited awareness among patients and healthcare providers.
Value Chain Analysis
- Raw Material Suppliers – Electronic components, biomaterials, and specialized heating technologies.
- Manufacturers – Global and regional producers of hyperthermia devices.
- Distributors/Wholesalers – Hospital supply chains and oncology equipment retailers.
- Healthcare Providers – Hospitals, clinics, and research institutes.
- Patients – End users benefiting from improved cancer treatment outcomes.
Quick Recommendations for Stakeholders
- Manufacturers: Invest in non-invasive, AI-integrated hyperthermia devices to capture premium demand.
- Distributors: Strengthen partnerships with hospitals and oncology centers.
- Investors: Focus on companies innovating in combination therapies and portable hyperthermia systems.
- Policy Makers: Support reimbursement policies and affordable access to hyperthermia treatments.
- Healthcare Providers: Integrate hyperthermia into oncology protocols for improved patient outcomes.
Table of Contents
Global Hyperthermia Treatment for Cancer Sales Market Report 2018
1 Hyperthermia Treatment for Cancer Market Overview
1.1 Product Overview and Scope of Hyperthermia Treatment for Cancer
1.2 Classification of Hyperthermia Treatment for Cancer by Product Category
1.2.1 Global Hyperthermia Treatment for Cancer Market Size (Sales) Comparison by Type
1.2.2 Global Hyperthermia Treatment for Cancer Market Size (Sales) Market Share by Type (Product Category) in
1.2.3 Microwave Hyperthermia Device
1.2.4 Ultrasound Hyperthermia Device
1.2.5 Infrared Therapy Device
1.2.6 Short-wave Therapy Device
1.3 Global Hyperthermia Treatment for Cancer Market by Application/End Users
1.3.1 Global Hyperthermia Treatment for Cancer Sales (Volume) and Market Share Comparison by Application
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Research Institutes
1.4 Global Hyperthermia Treatment for Cancer Market by Region
1.4.1 Global Hyperthermia Treatment for Cancer Market Size (Value) Comparison by Region
1.4.2 United States Hyperthermia Treatment for Cancer Status and Prospect
1.4.3 Europe Hyperthermia Treatment for Cancer Status and Prospect
1.4.4 China Hyperthermia Treatment for Cancer Status and Prospect
1.4.5 Japan Hyperthermia Treatment for Cancer Status and Prospect
1.4.6 Southeast Asia Hyperthermia Treatment for Cancer Status and Prospect
1.4.7 India Hyperthermia Treatment for Cancer Status and Prospect
1.5 Global Market Size (Value and Volume) of Hyperthermia Treatment for Cancer
1.5.1 Global Hyperthermia Treatment for Cancer Sales and Growth Rate
1.5.2 Global Hyperthermia Treatment for Cancer Revenue and Growth Rate
2 Global Hyperthermia Treatment for Cancer Competition by Players/Suppliers, Type and Application
2.1 Global Hyperthermia Treatment for Cancer Market Competition by Players/Suppliers
2.1.1 Global Hyperthermia Treatment for Cancer Sales and Market Share of Key Players/Suppliers ()
2.1.2 Global Hyperthermia Treatment for Cancer Revenue and Share by Players/Suppliers ()
2.2 Global Hyperthermia Treatment for Cancer (Volume and Value) by Type
2.2.1 Global Hyperthermia Treatment for Cancer Sales and Market Share by Type ()
2.2.2 Global Hyperthermia Treatment for Cancer Revenue and Market Share by Type ()
2.3 Global Hyperthermia Treatment for Cancer (Volume and Value) by Region
2.3.1 Global Hyperthermia Treatment for Cancer Sales and Market Share by Region ()
2.3.2 Global Hyperthermia Treatment for Cancer Revenue and Market Share by Region ()
2.4 Global Hyperthermia Treatment for Cancer (Volume) by Application
3 United States Hyperthermia Treatment for Cancer (Volume, Value and Sales Price)
3.1 United States Hyperthermia Treatment for Cancer Sales and Value ()
3.1.1 United States Hyperthermia Treatment for Cancer Sales and Growth Rate ()
3.1.2 United States Hyperthermia Treatment for Cancer Revenue and Growth Rate ()
3.1.3 United States Hyperthermia Treatment for Cancer Sales Price Trend ()
3.2 United States Hyperthermia Treatment for Cancer Sales Volume and Market Share by Players ()
3.3 United States Hyperthermia Treatment for Cancer Sales Volume and Market Share by Type ()
3.4 United States Hyperthermia Treatment for Cancer Sales Volume and Market Share by Application ()
4 Europe Hyperthermia Treatment for Cancer (Volume, Value and Sales Price)
4.1 Europe Hyperthermia Treatment for Cancer Sales and Value ()
4.1.1 Europe Hyperthermia Treatment for Cancer Sales and Growth Rate ()
4.1.2 Europe Hyperthermia Treatment for Cancer Revenue and Growth Rate ()
4.1.3 Europe Hyperthermia Treatment for Cancer Sales Price Trend ()
4.2 Europe Hyperthermia Treatment for Cancer Sales Volume and Market Share by Players ()
4.3 Europe Hyperthermia Treatment for Cancer Sales Volume and Market Share by Type ()
4.4 Europe Hyperthermia Treatment for Cancer Sales Volume and Market Share by Application ()
5 China Hyperthermia Treatment for Cancer (Volume, Value and Sales Price)
5.1 China Hyperthermia Treatment for Cancer Sales and Value ()
5.1.1 China Hyperthermia Treatment for Cancer Sales and Growth Rate ()
5.1.2 China Hyperthermia Treatment for Cancer Revenue and Growth Rate ()
5.1.3 China Hyperthermia Treatment for Cancer Sales Price Trend ()
5.2 China Hyperthermia Treatment for Cancer Sales Volume and Market Share by Players ()
5.3 China Hyperthermia Treatment for Cancer Sales Volume and Market Share by Type ()
5.4 China Hyperthermia Treatment for Cancer Sales Volume and Market Share by Application ()
6 Japan Hyperthermia Treatment for Cancer (Volume, Value and Sales Price)
6.1 Japan Hyperthermia Treatment for Cancer Sales and Value ()
6.1.1 Japan Hyperthermia Treatment for Cancer Sales and Growth Rate ()
6.1.2 Japan Hyperthermia Treatment for Cancer Revenue and Growth Rate ()
6.1.3 Japan Hyperthermia Treatment for Cancer Sales Price Trend ()
6.2 Japan Hyperthermia Treatment for Cancer Sales Volume and Market Share by Players ()
6.3 Japan Hyperthermia Treatment for Cancer Sales Volume and Market Share by Type ()
6.4 Japan Hyperthermia Treatment for Cancer Sales Volume and Market Share by Application ()
7 Southeast Asia Hyperthermia Treatment for Cancer (Volume, Value and Sales Price)
7.1 Southeast Asia Hyperthermia Treatment for Cancer Sales and Value ()
7.1.1 Southeast Asia Hyperthermia Treatment for Cancer Sales and Growth Rate ()
7.1.2 Southeast Asia Hyperthermia Treatment for Cancer Revenue and Growth Rate ()
7.1.3 Southeast Asia Hyperthermia Treatment for Cancer Sales Price Trend ()
7.2 Southeast Asia Hyperthermia Treatment for Cancer Sales Volume and Market Share by Players ()
7.3 Southeast Asia Hyperthermia Treatment for Cancer Sales Volume and Market Share by Type ()
7.4 Southeast Asia Hyperthermia Treatment for Cancer Sales Volume and Market Share by Application ()
8 India Hyperthermia Treatment for Cancer (Volume, Value and Sales Price)
8.1 India Hyperthermia Treatment for Cancer Sales and Value ()
8.1.1 India Hyperthermia Treatment for Cancer Sales and Growth Rate ()
8.1.2 India Hyperthermia Treatment for Cancer Revenue and Growth Rate ()
8.1.3 India Hyperthermia Treatment for Cancer Sales Price Trend ()
8.2 India Hyperthermia Treatment for Cancer Sales Volume and Market Share by Players ()
8.3 India Hyperthermia Treatment for Cancer Sales Volume and Market Share by Type ()
8.4 India Hyperthermia Treatment for Cancer Sales Volume and Market Share by Application ()
9 Global Hyperthermia Treatment for Cancer Players/Suppliers Profiles and Sales Data
9.1 Andromedic Sri
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Hyperthermia Treatment for Cancer Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Andromedic Sri Hyperthermia Treatment for Cancer Sales, Revenue, Price and Gross Margin ()
9.1.4 Main Business/Business Overview
9.2 Celsius42 GmbH
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Hyperthermia Treatment for Cancer Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Celsius42 GmbH Hyperthermia Treatment for Cancer Sales, Revenue, Price and Gross Margin ()
9.2.4 Main Business/Business Overview
9.3 Huahang
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Hyperthermia Treatment for Cancer Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Huahang Hyperthermia Treatment for Cancer Sales, Revenue, Price and Gross Margin ()
9.3.4 Main Business/Business Overview
9.4 Pyrexar Medical
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Hyperthermia Treatment for Cancer Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Pyrexar Medical Hyperthermia Treatment for Cancer Sales, Revenue, Price and Gross Margin ()
9.4.4 Main Business/Business Overview
9.5 Perseon Medical
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Hyperthermia Treatment for Cancer Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Perseon Medical Hyperthermia Treatment for Cancer Sales, Revenue, Price and Gross Margin ()
9.5.4 Main Business/Business Overview
9.6 Omron Corporation
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Hyperthermia Treatment for Cancer Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Omron Corporation Hyperthermia Treatment for Cancer Sales, Revenue, Price and Gross Margin ()
9.6.4 Main Business/Business Overview
9.7 Sjn AG Yamamoto Vinita
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Hyperthermia Treatment for Cancer Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Sjn AG Yamamoto Vinita Hyperthermia Treatment for Cancer Sales, Revenue, Price and Gross Margin ()
9.7.4 Main Business/Business Overview
...
10 Hyperthermia Treatment for Cancer Maufacturing Cost Analysis
10.1 Hyperthermia Treatment for Cancer Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Hyperthermia Treatment for Cancer
10.3 Manufacturing Process Analysis of Hyperthermia Treatment for Cancer
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Hyperthermia Treatment for Cancer Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Hyperthermia Treatment for Cancer Major Manufacturers in
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Hyperthermia Treatment for Cancer Market Forecast (2018-2025)
14.1 Global Hyperthermia Treatment for Cancer Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Hyperthermia Treatment for Cancer Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Hyperthermia Treatment for Cancer Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Hyperthermia Treatment for Cancer Price and Trend Forecast (2018-2025)
14.2 Global Hyperthermia Treatment for Cancer Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Hyperthermia Treatment for Cancer Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Hyperthermia Treatment for Cancer Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Hyperthermia Treatment for Cancer Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Hyperthermia Treatment for Cancer Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Hyperthermia Treatment for Cancer Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Hyperthermia Treatment for Cancer Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Hyperthermia Treatment for Cancer Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Hyperthermia Treatment for Cancer Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Hyperthermia Treatment for Cancer Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Hyperthermia Treatment for Cancer Sales Forecast by Type (2018-2025)
14.3.2 Global Hyperthermia Treatment for Cancer Revenue Forecast by Type (2018-2025)
14.3.3 Global Hyperthermia Treatment for Cancer Price Forecast by Type (2018-2025)
14.4 Global Hyperthermia Treatment for Cancer Sales Volume Forecast by Application (2018-2025)
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Hyperthermia Treatment for Cancer
Figure Global Hyperthermia Treatment for Cancer Sales Volume Comparison (K Units) by Type
Figure Global Hyperthermia Treatment for Cancer Sales Volume Market Share by Type (Product Category) in
Figure Microwave Hyperthermia Device Product Picture
Figure Ultrasound Hyperthermia Device Product Picture
Figure Infrared Therapy Device Product Picture
Figure Short-wave Therapy Device Product Picture
Figure Global Hyperthermia Treatment for Cancer Sales Comparison (K Units) by Application
Figure Global Sales Market Share of Hyperthermia Treatment for Cancer by Application in
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Research Institutes Examples
Table Key Downstream Customer in Research Institutes
Figure Global Hyperthermia Treatment for Cancer Market Size (Million USD) by Regions
Figure United States Hyperthermia Treatment for Cancer Revenue (Million USD) and Growth Rate
Figure Europe Hyperthermia Treatment for Cancer Revenue (Million USD) and Growth Rate
Figure China Hyperthermia Treatment for Cancer Revenue (Million USD) and Growth Rate
Figure Japan Hyperthermia Treatment for Cancer Revenue (Million USD) and Growth Rate
Figure Southeast Asia Hyperthermia Treatment for Cancer Revenue (Million USD) and Growth Rate
Figure India Hyperthermia Treatment for Cancer Revenue (Million USD) and Growth Rate
Figure Global Hyperthermia Treatment for Cancer Sales Volume (K Units) and Growth Rate
Figure Global Hyperthermia Treatment for Cancer Revenue (Million USD) and Growth Rate
Figure Global Market Major Players Hyperthermia Treatment for Cancer Sales Volume (K Units) ()
Table Global Hyperthermia Treatment for Cancer Sales (K Units) of Key Players/Suppliers ()
Table Global Hyperthermia Treatment for Cancer Sales Share by Players/Suppliers ()
Figure Hyperthermia Treatment for Cancer Sales Share by Players/Suppliers
Figure Hyperthermia Treatment for Cancer Sales Share by Players/Suppliers
Figure Global Hyperthermia Treatment for Cancer Revenue (Million USD) by Players/Suppliers ()
Table Global Hyperthermia Treatment for Cancer Revenue (Million USD) by Players/Suppliers ()
Table Global Hyperthermia Treatment for Cancer Revenue Share by Players/Suppliers ()
Table Global Hyperthermia Treatment for Cancer Revenue Share by Players
Table Global Hyperthermia Treatment for Cancer Revenue Share by Players
Table Global Hyperthermia Treatment for Cancer Sales (K Units) and Market Share by Type ()
Table Global Hyperthermia Treatment for Cancer Sales Share (K Units) by Type ()
Figure Sales Market Share of Hyperthermia Treatment for Cancer by Type ()
Figure Global Hyperthermia Treatment for Cancer Sales Growth Rate by Type ()
Table Global Hyperthermia Treatment for Cancer Revenue (Million USD) and Market Share by Type ()
Table Global Hyperthermia Treatment for Cancer Revenue Share by Type ()
Figure Revenue Market Share of Hyperthermia Treatment for Cancer by Type ()
Figure Global Hyperthermia Treatment for Cancer Revenue Growth Rate by Type ()
Table Global Hyperthermia Treatment for Cancer Sales Volume (K Units) and Market Share by Region ()
Table Global Hyperthermia Treatment for Cancer Sales Share by Region ()
Figure Sales Market Share of Hyperthermia Treatment for Cancer by Region ()
Figure Global Hyperthermia Treatment for Cancer Sales Growth Rate by Region in
Table Global Hyperthermia Treatment for Cancer Revenue (Million USD) and Market Share by Region ()
Table Global Hyperthermia Treatment for Cancer Revenue Share (%) by Region ()
Figure Revenue Market Share of Hyperthermia Treatment for Cancer by Region ()
Figure Global Hyperthermia Treatment for Cancer Revenue Growth Rate by Region in
Table Global Hyperthermia Treatment for Cancer Revenue (Million USD) and Market Share by Region ()
Table Global Hyperthermia Treatment for Cancer Revenue Share (%) by Region ()
Figure Revenue Market Share of Hyperthermia Treatment for Cancer by Region ()
Figure Global Hyperthermia Treatment for Cancer Revenue Market Share by Region in
Table Global Hyperthermia Treatment for Cancer Sales Volume (K Units) and Market Share by Application ()
Table Global Hyperthermia Treatment for Cancer Sales Share (%) by Application ()
Figure Sales Market Share of Hyperthermia Treatment for Cancer by Application ()
Figure Global Hyperthermia Treatment for Cancer Sales Market Share by Application ()
Figure United States Hyperthermia Treatment for Cancer Sales (K Units) and Growth Rate ()
Figure United States Hyperthermia Treatment for Cancer Revenue (Million USD) and Growth Rate ()
Figure United States Hyperthermia Treatment for Cancer Sales Price (USD/Unit) Trend ()
Table United States Hyperthermia Treatment for Cancer Sales Volume (K Units) by Players ()
Table United States Hyperthermia Treatment for Cancer Sales Volume Market Share by Players ()
Figure United States Hyperthermia Treatment for Cancer Sales Volume Market Share by Players in
Table United States Hyperthermia Treatment for Cancer Sales Volume (K Units) by Type ()
Table United States Hyperthermia Treatment for Cancer Sales Volume Market Share by Type ()
Figure United States Hyperthermia Treatment for Cancer Sales Volume Market Share by Type in
Table United States Hyperthermia Treatment for Cancer Sales Volume (K Units) by Application ()
Table United States Hyperthermia Treatment for Cancer Sales Volume Market Share by Application ()
Figure United States Hyperthermia Treatment for Cancer Sales Volume Market Share by Application in
Figure Europe Hyperthermia Treatment for Cancer Sales (K Units) and Growth Rate ()
Figure Europe Hyperthermia Treatment for Cancer Revenue (Million USD) and Growth Rate ()
Figure Europe Hyperthermia Treatment for Cancer Sales Price (USD/Unit) Trend ()
Table Europe Hyperthermia Treatment for Cancer Sales Volume (K Units) by Players ()
Table Europe Hyperthermia Treatment for Cancer Sales Volume Market Share by Players ()
Figure Europe Hyperthermia Treatment for Cancer Sales Volume Market Share by Players in
Table Europe Hyperthermia Treatment for Cancer Sales Volume (K Units) by Type ()
Table Europe Hyperthermia Treatment for Cancer Sales Volume Market Share by Type ()
Figure Europe Hyperthermia Treatment for Cancer Sales Volume Market Share by Type in
Table Europe Hyperthermia Treatment for Cancer Sales Volume (K Units) by Application ()
Table Europe Hyperthermia Treatment for Cancer Sales Volume Market Share by Application ()
Figure Europe Hyperthermia Treatment for Cancer Sales Volume Market Share by Application in
Figure China Hyperthermia Treatment for Cancer Sales (K Units) and Growth Rate ()
Figure China Hyperthermia Treatment for Cancer Revenue (Million USD) and Growth Rate ()
Figure China Hyperthermia Treatment for Cancer Sales Price (USD/Unit) Trend ()
Table China Hyperthermia Treatment for Cancer Sales Volume (K Units) by Players ()
Table China Hyperthermia Treatment for Cancer Sales Volume Market Share by Players ()
Figure China Hyperthermia Treatment for Cancer Sales Volume Market Share by Players in
Table China Hyperthermia Treatment for Cancer Sales Volume (K Units) by Type ()
Table China Hyperthermia Treatment for Cancer Sales Volume Market Share by Type ()
Figure China Hyperthermia Treatment for Cancer Sales Volume Market Share by Type in
Table China Hyperthermia Treatment for Cancer Sales Volume (K Units) by Application ()
Table China Hyperthermia Treatment for Cancer Sales Volume Market Share by Application ()
Figure China Hyperthermia Treatment for Cancer Sales Volume Market Share by Application in
Figure Japan Hyperthermia Treatment for Cancer Sales (K Units) and Growth Rate ()
Figure Japan Hyperthermia Treatment for Cancer Revenue (Million USD) and Growth Rate ()
Figure Japan Hyperthermia Treatment for Cancer Sales Price (USD/Unit) Trend ()
Table Japan Hyperthermia Treatment for Cancer Sales Volume (K Units) by Players ()
Table Japan Hyperthermia Treatment for Cancer Sales Volume Market Share by Players ()
Figure Japan Hyperthermia Treatment for Cancer Sales Volume Market Share by Players in
Table Japan Hyperthermia Treatment for Cancer Sales Volume (K Units) by Type ()
Table Japan Hyperthermia Treatment for Cancer Sales Volume Market Share by Type ()
Figure Japan Hyperthermia Treatment for Cancer Sales Volume Market Share by Type in
Table Japan Hyperthermia Treatment for Cancer Sales Volume (K Units) by Application ()
Table Japan Hyperthermia Treatment for Cancer Sales Volume Market Share by Application ()
Figure Japan Hyperthermia Treatment for Cancer Sales Volume Market Share by Application in
Figure Southeast Asia Hyperthermia Treatment for Cancer Sales (K Units) and Growth Rate ()
Figure Southeast Asia Hyperthermia Treatment for Cancer Revenue (Million USD) and Growth Rate ()
Figure Southeast Asia Hyperthermia Treatment for Cancer Sales Price (USD/Unit) Trend ()
Table Southeast Asia Hyperthermia Treatment for Cancer Sales Volume (K Units) by Players ()
Table Southeast Asia Hyperthermia Treatment for Cancer Sales Volume Market Share by Players ()
Figure Southeast Asia Hyperthermia Treatment for Cancer Sales Volume Market Share by Players in
Table Southeast Asia Hyperthermia Treatment for Cancer Sales Volume (K Units) by Type ()
Table Southeast Asia Hyperthermia Treatment for Cancer Sales Volume Market Share by Type ()
Figure Southeast Asia Hyperthermia Treatment for Cancer Sales Volume Market Share by Type in
Table Southeast Asia Hyperthermia Treatment for Cancer Sales Volume (K Units) by Application ()
Table Southeast Asia Hyperthermia Treatment for Cancer Sales Volume Market Share by Application ()
Figure Southeast Asia Hyperthermia Treatment for Cancer Sales Volume Market Share by Application in
Figure India Hyperthermia Treatment for Cancer Sales (K Units) and Growth Rate ()
Figure India Hyperthermia Treatment for Cancer Revenue (Million USD) and Growth Rate ()
Figure India Hyperthermia Treatment for Cancer Sales Price (USD/Unit) Trend ()
Table India Hyperthermia Treatment for Cancer Sales Volume (K Units) by Players ()
Table India Hyperthermia Treatment for Cancer Sales Volume Market Share by Players ()
Figure India Hyperthermia Treatment for Cancer Sales Volume Market Share by Players in
Table India Hyperthermia Treatment for Cancer Sales Volume (K Units) by Type ()
Table India Hyperthermia Treatment for Cancer Sales Volume Market Share by Type ()
Figure India Hyperthermia Treatment for Cancer Sales Volume Market Share by Type in
Table India Hyperthermia Treatment for Cancer Sales Volume (K Units) by Application ()
Table India Hyperthermia Treatment for Cancer Sales Volume Market Share by Application ()
Figure India Hyperthermia Treatment for Cancer Sales Volume Market Share by Application in
Table Andromedic Sri Basic Information List
Table Andromedic Sri Hyperthermia Treatment for Cancer Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin ()
Figure Andromedic Sri Hyperthermia Treatment for Cancer Sales Growth Rate ()
Figure Andromedic Sri Hyperthermia Treatment for Cancer Sales Global Market Share ()
Figure Andromedic Sri Hyperthermia Treatment for Cancer Revenue Global Market Share ()
Table Celsius42 GmbH Basic Information List
Table Celsius42 GmbH Hyperthermia Treatment for Cancer Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin ()
Figure Celsius42 GmbH Hyperthermia Treatment for Cancer Sales Growth Rate ()
Figure Celsius42 GmbH Hyperthermia Treatment for Cancer Sales Global Market Share ()
Figure Celsius42 GmbH Hyperthermia Treatment for Cancer Revenue Global Market Share ()
Table Huahang Basic Information List
Table Huahang Hyperthermia Treatment for Cancer Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin ()
Figure Huahang Hyperthermia Treatment for Cancer Sales Growth Rate ()
Figure Huahang Hyperthermia Treatment for Cancer Sales Global Market Share (
Figure Huahang Hyperthermia Treatment for Cancer Revenue Global Market Share ()
Table Pyrexar Medical Basic Information List
Table Pyrexar Medical Hyperthermia Treatment for Cancer Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin ()
Figure Pyrexar Medical Hyperthermia Treatment for Cancer Sales Growth Rate ()
Figure Pyrexar Medical Hyperthermia Treatment for Cancer Sales Global Market Share ()
Figure Pyrexar Medical Hyperthermia Treatment for Cancer Revenue Global Market Share ()
Table Perseon Medical Basic Information List
Table Perseon Medical Hyperthermia Treatment for Cancer Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin ()
Figure Perseon Medical Hyperthermia Treatment for Cancer Sales Growth Rate ()
Figure Perseon Medical Hyperthermia Treatment for Cancer Sales Global Market Share ()
Figure Perseon Medical Hyperthermia Treatment for Cancer Revenue Global Market Share ()
Table Omron Corporation Basic Information List
Table Omron Corporation Hyperthermia Treatment for Cancer Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin ()
Figure Omron Corporation Hyperthermia Treatment for Cancer Sales Growth Rate ()
Figure Omron Corporation Hyperthermia Treatment for Cancer Sales Global Market Share (
Figure Omron Corporation Hyperthermia Treatment for Cancer Revenue Global Market Share ()
Table Sjn AG Yamamoto Vinita Basic Information List
Table Sjn AG Yamamoto Vinita Hyperthermia Treatment for Cancer Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin ()
Figure Sjn AG Yamamoto Vinita Hyperthermia Treatment for Cancer Sales Growth Rate ()
Figure Sjn AG Yamamoto Vinita Hyperthermia Treatment for Cancer Sales Global Market Share ()
Figure Sjn AG Yamamoto Vinita Hyperthermia Treatment for Cancer Revenue Global Market Share ()
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hyperthermia Treatment for Cancer
Figure Manufacturing Process Analysis of Hyperthermia Treatment for Cancer
Figure Hyperthermia Treatment for Cancer Industrial Chain Analysis
Table Raw Materials Sources of Hyperthermia Treatment for Cancer Major Players in
Table Major Buyers of Hyperthermia Treatment for Cancer
Table Distributors/Traders List
Figure Global Hyperthermia Treatment for Cancer Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Hyperthermia Treatment for Cancer Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Hyperthermia Treatment for Cancer Price (USD/Unit) and Trend Forecast (2018-2025)
Table Global Hyperthermia Treatment for Cancer Sales Volume (K Units) Forecast by Regions (2018-2025)
Figure Global Hyperthermia Treatment for Cancer Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Hyperthermia Treatment for Cancer Sales Volume Market Share Forecast by Regions in 2025
Table Global Hyperthermia Treatment for Cancer Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Hyperthermia Treatment for Cancer Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Hyperthermia Treatment for Cancer Revenue Market Share Forecast by Regions in 2025
Figure United States Hyperthermia Treatment for Cancer Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Hyperthermia Treatment for Cancer Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Hyperthermia Treatment for Cancer Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Hyperthermia Treatment for Cancer Revenue and Growth Rate Forecast (2018-2025)
Figure China Hyperthermia Treatment for Cancer Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure China Hyperthermia Treatment for Cancer Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Hyperthermia Treatment for Cancer Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Hyperthermia Treatment fo
Key Players
In addition to the listed manufacturers, the following companies are also significant participants in the global hyperthermia treatment for cancer market:
- Andromedic Sri (Italy)
- Celsius42 GmbH (Germany)
- Huahang (China)
- Pyrexar Medical (US)
- Perseon Medical (US)
- Omron Corporation (Japan)
- Sjn AG Yamamoto Vinita (Japan)
- BSD Medical (US)
- Oncotherm Kft. (Hungary)
- ThermoTek Inc. (US)
- MedicaTherm (Germany)
- Alba Hyperthermia Systems (Spain)
These players compete on innovation, device safety, clinical validation, regulatory approvals, and distribution networks.
Segments Analysis
By Product Type
- Microwave Hyperthermia Devices – Widely used for localized tumor heating.
- Ultrasound Hyperthermia Devices – Non-invasive, precise targeting of tumor tissues.
- Infrared Therapy Devices – Applied for superficial tumors.
- Short-wave Therapy Devices – Used for deep tissue heating.
By Application
- Hospitals – Largest segment; demand driven by oncology departments.
- Clinics – Growing adoption in outpatient cancer treatment centers.
- Research Institutes – Focused on clinical trials, innovation, and device validation.
Regional Analysis
- North America – Largest market; US leads due to advanced oncology infrastructure and high cancer prevalence.
- Europe – Significant adoption in Germany, UK, and France; focus on clinical validation and reimbursement policies.
- Asia-Pacific – Fastest-growing region; China, India, and Japan drive growth due to rising cancer cases and expanding healthcare facilities.
- South America – Brazil and Argentina show increasing adoption in urban hospitals.
- Middle East & Africa – Emerging demand in Saudi Arabia, Turkey, and South Africa, supported by expanding oncology care infrastructure.
